Please assess the completion status of the following clinical trial:

Trial Title: Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-80 years~* Dependent upon daily PPIs for \> 6 months~* Troublesome symptoms, specifically heartburn or regurgitation, while on 40 mg of omeprazole or equivalent.~Troublesome heartburn or regurgitation symptoms are those which occur a minimum of 2-3 days a week and are at least moderate in severity.~* Abnormal ambulatory pH study off PPI therapy for 7 days.~* Normal or near normal esophageal motility (by manometry)~* Hiatal hernia axial height is no larger than 2 cm and the transverse dimension should not exceed 2.5 cm~* Patient willing to cooperate with post-operative dietary recommendations and assessment tests~* Signed informed consent~Exclusion Criteria:~* BMI \> 35~* Hiatal hernia \> 2 cm~* Esophagitis Los Angeles grade C or D~* Esophageal ulcer~* Esophageal stricture~* Esophageal motility disorder~* Pregnancy or plans for pregnancy in the next 12 months (in females)~* Immunosuppression~* ASA \> 2~* Portal hypertension and/or varices~* History of previous resective gastric or esophageal surgery, cervical spine fusion, Zenker's diverticulum, esophageal epiphrenic diverticulum, achalasia, scleroderma or dermatomyositis, eosinophilic esophagitis, or cirrhosis~* Active gastro-duodenal ulcer disease~* Gastric outlet obstruction or stenosis~* Severe gastroparesis or delayed gastric emptying confirmed by solid-phase gastric emptying study if patient complains of postprandial satiety during assessment~* Coagulation disorders~* Interprocedural determination of anatomical presentation which in the opinion of the surgeon does not allow safe device introduction.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Sham placebo procedure (Type: PLACEBO_COMPARATOR): Sham Procedure: SHAM/PPI's An upper GI Endoscopy is performed with a standard endoscope, during 30-45 minutes. The patient is under general anesthesia. EGD explores the esophagus, the stomach, and the GEJ.
- TIF Transoral Fundoplication (Type: ACTIVE_COMPARATOR): Intervention: TIF 2.0/Placebo TIF Transoral Incisionless Fundoplication: A fundoplication of 270 degrees and 3cm in length was created. The EsophyX device is introduced over a standard endoscope, through the mouth, into the stomach.

Based on this trial design, predict the completion outcome and termination type (if applicable).